Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Nature Cancer|March 1, 2024
Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor StudyPeter M K de Blank, Katharine R Lange, Mengqi Xing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumorSusan N Chi, Mary Ann Zimmerman, Xiaopan Yao, et al.
Acta Neuropathologica|December 23, 2019
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2019
Germline GPR161 Mutations Predispose to Pediatric MedulloblastomaMatthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyAmar Gajjar, Anita Mahajan, Mohamed Abdelbaki, et al.
Neuro-Oncology|April 13, 2019
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trialSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAmar Gajjar, Anita Mahajan, Tejus Bale, et al.
Neuro-Oncology|October 11, 2017
Pediatric low-grade gliomas: next biologically driven stepsDavid T W Jones, Mark W Kieran, Eric Bouffet, et al.
The Lancet. Oncology|October 27, 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.
Pageof 9